PMID- 31367236 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220409 IS - 1758-5996 (Print) IS - 1758-5996 (Electronic) IS - 1758-5996 (Linking) VI - 11 DP - 2019 TI - Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin. PG - 59 LID - 10.1186/s13098-019-0452-8 [doi] LID - 59 AB - OBJECTIVE: To study the prevalence of postprandial hyperglycaemia (PPH) in type 2 diabetes mellitus (T2DM) patients treated with basal insulin, having fasting glucose < 130 mg/dL but HbA1c > 7.0% (53 mmol/mol). METHODS: This was an observational prospective multicentric study conducted in Spain. During 2 weeks, patients recorded a 6-point self-measured blood glucose profile (before and 2 h after eating) every 2 days. PPH was defined according to IDF and ADA guidelines (> 160 and > 180 mg/dL, respectively). RESULTS: We included 98 patients (males: 56.1%; mean age: 64.3 +/- 10.4 years) who were treated with basal insulin for at least 1 year at stable doses in the last 2 months, 88.8% of them received concomitant oral antidiabetic drugs. Overall, 95.7% (95% CI 91.6-99.8) and 93.5% (95% CI 88.6-98.5) of patients showed >/= 1 episode of PPH according to IDF and ADA criteria respectively. PPH was more frequently observed after lunch and dinner. The proportion of patients with >/= 40% readings in range of PPH was 59.1% (95% CI 49.1-69.1) and 40.9% (95% CI 30.9-50.9), according to IDF and ADA criteria, respectively. CONCLUSIONS: PPH is very common and should be considered a priority target in basal insulin-treated T2DM patients with elevated HbA1c despite controlled fasting glucose. FAU - Tinahones, Francisco J AU - Tinahones FJ AD - 1Hospital Universitario Virgen de la Victoria, Servicio de Endocrinologia, Campus Universitario de Teatinos s/n., 29010 Malaga, Spain. ISNI: 0000 0000 9788 2492. GRID: grid.411062.0 AD - 2CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Malaga, Spain. ISNI: 0000 0000 9314 1427. GRID: grid.413448.e FAU - Molina-Vega, Maria AU - Molina-Vega M AUID- ORCID: 0000-0002-0147-4369 AD - 1Hospital Universitario Virgen de la Victoria, Servicio de Endocrinologia, Campus Universitario de Teatinos s/n., 29010 Malaga, Spain. ISNI: 0000 0000 9788 2492. GRID: grid.411062.0 FAU - Parra-Barona, Juan AU - Parra-Barona J AD - Hospital de Merida, Merida, Spain. FAU - Flores-Le Roux, Juana AU - Flores-Le Roux J AD - 4Hospital del Mar, Barcelona, Spain. ISNI: 0000 0004 1767 8811. GRID: grid.411142.3 FAU - Gomez-Huelgas, Ricardo AU - Gomez-Huelgas R AD - 5Hospital Universitario Regional, Servicio de Medicina Interna, FIMABIS, Malaga, Spain. GRID: grid.428833.6 LA - eng PT - Journal Article DEP - 20190724 PL - England TA - Diabetol Metab Syndr JT - Diabetology & metabolic syndrome JID - 101488958 PMC - PMC6657157 OTO - NOTNLM OT - HbA1c OT - Hyperglycaemia OT - Postprandial glucose OT - Type 2 diabetes mellitus COIS- Competing interestsThe authors declared that they have no competing interests. EDAT- 2019/08/02 06:00 MHDA- 2019/08/02 06:01 PMCR- 2019/07/24 CRDT- 2019/08/02 06:00 PHST- 2019/03/12 00:00 [received] PHST- 2019/07/03 00:00 [accepted] PHST- 2019/08/02 06:00 [entrez] PHST- 2019/08/02 06:00 [pubmed] PHST- 2019/08/02 06:01 [medline] PHST- 2019/07/24 00:00 [pmc-release] AID - 452 [pii] AID - 10.1186/s13098-019-0452-8 [doi] PST - epublish SO - Diabetol Metab Syndr. 2019 Jul 24;11:59. doi: 10.1186/s13098-019-0452-8. eCollection 2019.